DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Editorial Message and Issue Highlights–Vol. 16, No. 3–4, March-April 2019

Dear Colleagues: Welcome to the March–April 2019 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a Psychotherapy Rounds submission titled, “Addiction Disorder Considerations in Patients Seeking

The Pathophysiology of Marijuana-induced Encephalopathy and Possible Epilepsy after Ingestion in Children: A Case Series

by Alister Carvalho, MBBS, and Tracy Evans-Gilbert, DM, MPH, CTropMed® Drs. Carvalho and Evans-Gilbert are with the Department of Pediatrics at the Cornwall Regional Hospital in Montego Bay, Jamaica. Dr.

Panic Attacks in Hyperaldosteronism

by Tiffany Y. Lin, MD; Rebecca M. Hedrick, MD; and Waguih William IsHak, MD, FAPA Drs. Lin and IsHak are with the David Geffen School of Medicine at University of

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

by Laetitia Pouzol, MSc, PharmD; Luca Piali, PhD; Claude CA Bernard, PhD; Marianne M. Martinic, PhD; Beat Steiner, PhD; and Martine Clozel, MD Drs. Pouzol and Clozel were with Actelion

The Top Three Things to Know about the Top Three Risk Management Issues

by Charles D. Cash, JD, LLM Mr. Cash is Assistant Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: